In the context of fortifying the cooperation between Rontis and Overseas Pharma, as well as promoting the sales of our dermaceutical brands novalou® & novatopia® into the Emirate of Qatar, the “1st Group Meeting novalou® & novatopia®” took place in Doha, on November 25th, 2016.
The event which was held in Doha’s Hilton Hotel in honor of local Key Opinion Leaders (KOLs) (pharmacists, pediatricians and dermatologists), included the Rontis Corporation presentation and detailed marketing presentation of the Consumer Healthcare product lines.
That Group Meeting had a valuable contribution to both parties, as Rontis has succeeded to further promote its international profile and the brand awareness of its products, while Overseas Pharma has achieved Qatar’s medical community’s trust and acceptance in order to develop its market share and profitability.
During the event we had the unique opportunity to meet with well-known & respected KOLs, whose contribution is of great importance in the establishment of novalou® & novatopia® brands into the maternity and pediatric clinics of Doha Clinic Hospital and Hamad General Hospital.
It’s worth mentioning that, even if, our distributor, Overseas Pharma, is a newly established company, is characterized by creative spirit, as it has succeeded in a short period of time to enter the pharmacy channel and attract the consumers’ interest.
Our target is to perform similar actions, as we do in all our other markets, in order for us to consolidate the new partnership, strengthen and establish our position in the Middle Eastern market!